revenue, IMI history etc. MOM has had several good news releases in a row, market cap is 11 million just on these. The SP will not "move" until we start to see what type of sales revenue they start to bring in, London Drugs has rolled out PreVu to 'test' in all their stores after the 'test' in the west, and we now have a' test' in the east with PharmaChoice. Potential....
Yesterdays announcement has good 'potential' revenue, doesnt mean it WILL will bring in revenue.... yet.
The key word on the Prevu is 'test' IMO. Sounds like they have put a small amount of inventory into these stores, (I havent seen anything in my local London Drug store yet (I am in the west). With the wording 'test', I would expect there is a return agreement if they do not 'test' well.
If you believe they will be successful, load up, I am buying today, I made some money when IMI had the product but could not launch, and expect to make some here.
For those of you who do not know the story there (IMI), the long and short of it, I bought at a buck, it maxed out at around 7, during the honeymoon phase of NR's on the PreVu test, partnership announcements (to bring it to market), excitement on getting US FDA approvals,and then the collapse as FDA approvals did not materialize and partnerships fell away..... back to pennies. If memory serves, it traded on the NASDAQ for a while as well........ I forget how many outstanding shares there were at the time for IMI, but certianly not 96 million (which hurts us IMO).
More dd here is required by all investors, what is their profit margin, how well is it selling, and ...... what big pharma is/maybe looking at this as a potential takeover......, the key here for any major SP 'gift' is proceeding with FDA approvals for PreVu in my opinion.
The story here may just be beginning ..... again.... IMO
Cheers,